Concepedia

Amy S. Rosenberg

AS

Statistics

Publications

54

Citations

4.6K

H-Index

31

Active since

1985

Affiliations

Center for Drug Evaluation and Research(Current)

United States Food and Drug Administration

Duke Medical Center

National Institutes of Health

National Cancer Institute

Amy S. Rosenberg is an author at Center for Drug Evaluation and Research specializing in immunology, life sciences, and clinical immunology.

Publications per year

1985–2024

54

Publications

54

Binding and Functional Comparisons of Two Types of Tumor Necrosis Factor Antagonists

Bernie Scallon, Ann Cai, Nancy Solowski et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 669 citations

, , +17

Overlooking Subvisible Particles in Therapeutic Protein Products: Gaps That May Compromise Product Quality

John F. Carpenter, Theodore W. Randolph, Wim Jiskoot et al. · Journal of Pharmaceutical Sciences · 2008 · 588 citations · Full text

, , +16

Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants

Priya S. Kishnani, Paula Goldenberg, Stephanie DeArmey et al. · Molecular Genetics and Metabolism · 2009 · 379 citations

, , +5

The impact of antibodies on clinical outcomes in diseases treated with therapeutic protein: Lessons learned from infantile Pompe disease

Suhrad G. Banugaria, Sean N. Prater, Yiu-Ki Ng et al. · Genetics in Medicine · 2011 · 251 citations · Full text

, , +15

Successful immune tolerance induction to enzyme replacement therapy in CRIM-negative infantile Pompe disease

Yoav H. Messinger, Nancy J. Mendelsohn, William J. Rhead et al. · Genetics in Medicine · 2012 · 211 citations · Full text

, , +12

1–5 of 54